e.krastev
Submits third-party assay reports on material purchased directly. Based in Debrecen.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
7
n=7
Annotations
0
n=0
Median purity submitted
98.97%
n=7
Suppliers covered
7
n=7
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042247 | BPC-157 | TFC | TFC-2511-S9305 | Janoshik | 2026-Q2 | 98.85 | 4.75 | 104.1 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042389 | Tirzepatide | Homopeptide | HOMO-2601-N4081 | Janoshik | 2026-Q2 | 98.97 | 4.63 | — | Buyer-sourced | 0 | PASS |
| AX-2026-043131 | BPC-157 | SSA | SSA-2601-N6863 | Janoshik | 2026-Q2 | 97.75 | 4.43 | 100.0 | Buyer-sourced | 1 | FAIL |
| AX-2026-041540 | Tirzepatide | QSC | QSC-2511-N6404 | PeptideMeter | 2026-Q1 | 98.98 | 1.87 | 96.9 | Buyer-sourced | 0 | PASS |
| AX-2025-020054 | Retatrutide | SWB | SWB-2503-P7565 | PeptideMeter | 2025-Q2 | 98.15 | 4.69 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019180 | Enclomiphene citrate | SinoPep | SNP-2412-F3914 | Nordanalyt | 2025-Q1 | 99.50 | 5.11 | 96.4 | Buyer-sourced | 1 | FAIL |
| AX-2025-019368 | GHRP-2 | HYB | HYB-2501-R7240 | Medutest | 2025-Q1 | 99.93 | 5.50 | 105.5 | Buyer-sourced | 1 | MARGINAL |